Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Skyharbour Enters into Agreements to Partner with Hatchet Uranium Corp. on Several of its Uranium Projects Located in the Athabasca Basin, Saskatchewan
-
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
-
Editas Medicine Announces Third Quarter 2024 Results and Business Updates
-
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
-
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
-
Abeona Therapeutics® Announces Participation in November Investor Conferences
-
Finance Expert Shinobu Hindert Leads Financial Literacy Workshop in Kenya to Empower Young Women
-
Incyclix Bio Announces Abstract Accepted for Presentation at 2024 San Antonio Breast Cancer Symposium
-
ElevateBio Appoints Amy Pooler, Ph.D., as Senior Vice President, Research and Development
-
Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board
-
Trading by management and close relations of management
-
Keynode Introduces Innovative Free Crypto Staking Plan, Empowering Users to Earn Passive Income
-
Form 8.3 - [ECKOH PLC - 01 11 2024] - (CGWL)
-
Ward Village® Welcomes Residents to Victoria Place® as Newest Residential Tower Opens in Acclaimed Howard Hughes Community in Honolulu
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia
-
Kraig Biocraft Laboratories Announces Successful Completion of Latest Recombinant Spider Silk Production Batch
-
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
-
Capital Southwest Announces Proposed Convertible Notes Offering
-
Tether Launches Holiday Gift Guide for Cannabis Retailers Across Ontario
-
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
-
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
-
AMG Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2024
-
Arvinas to Participate in Upcoming Investor Conferences
-
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
-
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
-
Kforce Inc. Announces Participation in the UBS Global Technology and AI Conference
-
Kamada to Present at the Stifel 2024 Healthcare Conference
-
American Lithium Provides Operations Update
-
Hatchet Uranium Corp. Signs Agreements with Skyharbour Resources Ltd. on Five Uranium Projects Located Northeast of the Athabasca Basin, Saskatchewan
-
StorageVault Acquires 2 Stores for $10,500,000
-
Canadian Premium Sand Inc. Provides Operational Update and Announces Plans for a US Facility
-
Alta Equipment Group Announces Common Stock Dividend
-
L’Ordre des CPA du Québec, CPA Ontario, and CPA Canada Reach Agreement on Standard Setting and Education
-
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
-
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
-
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
-
Opthea to Participate in November Investor Conferences
-
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
-
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
-
Sono-Tek Announces Share Buyback
-
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
-
Better Choice Company to Host Third Quarter 2024 Financial Results Conference Call on November 12th at 4:30 p.m. ET
-
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
-
Village Farms International Selected to Testify at Marijuana Rescheduling Hearing
-
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases
-
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
-
Coda Octopus Group Announces Acquisition of Precision Acoustics Limited
-
Colliers named one of Forbes’ World’s Best Employers 2024
-
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024

